Van Meter Says Ivantis Making Moves in MIGS

Dave Van Meter, president and CEO of Ivantis, explains how the company’s Hydrus Microstent plans to grab a piece of the growing MIGS market. He also shares why he shifted from interventional cardiology to ophthalmology and what challenges he overcame in making that switch.

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.